Comments
Loading...
Clene (NASDAQ:CLNN) Stock Quotes, Forecast and News Summary
Clene Stock (NASDAQ: CLNN) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Clene (CLNN) stock?
You can purchase shares of Clene (NASDAQ:CLNN) through any online brokerage.
Who are Clene (CLNN) competitors?
Other companies in Clene’s space includes: Outlook Therapeutics (NASDAQ:OTLK), OncoCyte (NASDAQ:OCX), Curis (NASDAQ:CRIS), Intensity Therapeutics (NASDAQ:INTS) and FibroGen (NASDAQ:FGEN).
What is the forecast, or price target, for Clene (CLNN) stock?
Clene has a consensus price target of $33.50.
What is the current price for Clene (CLNN)?
The stock price for Clene (NASDAQ: CLNN) is $4.3915 last updated December 18, 2024 at 1:21 PM EST.
Does Clene (CLNN) pay a dividend?
There are no upcoming dividends for Clene.
When is Clene (NASDAQ:CLNN) reporting earnings?
Clene’s Q4 earnings are confirmed for Wednesday, March 12, 2025.
Is Clene (CLNN) going to split?
There is no upcoming split for Clene.
What sector and industry does Clene (CLNN) operate in?
Clene is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.